Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan

Author:

van de Sandt Carolien E.ORCID,Nguyen Thi H. O.ORCID,Gherardin Nicholas A.ORCID,Crawford Jeremy ChaseORCID,Samir Jerome,Minervina Anastasia A.,Pogorelyy Mikhail V.,Rizzetto SimoneORCID,Szeto ChristopherORCID,Kaur Jasveen,Ranson NicoleORCID,Sonda Sabrina,Harper Alice,Redmond Samuel J.,McQuilten Hayley A.ORCID,Menon Tejas,Sant Sneha,Jia Xiaoxiao,Pedrina Kate,Karapanagiotidis Theo,Cain Natalie,Nicholson Suellen,Chen ZhenjunORCID,Lim Ratana,Clemens E. Bridie,Eltahla Auda,La Gruta Nicole L.ORCID,Crowe Jane,Lappas Martha,Rossjohn JamieORCID,Godfrey Dale I.,Thomas Paul G.ORCID,Gras StephanieORCID,Flanagan Katie L.ORCID,Luciani FabioORCID,Kedzierska KatherineORCID

Abstract

AbstractCD8+ T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear. Here we defined CD8+ T cell immunity directed at the prominent influenza epitope HLA-A*02:01-M158–66 (A2/M158) across four age groups at phenotypic, transcriptomic, clonal and functional levels. We identify a linear differentiation trajectory from newborns to children then adults, followed by divergence and a clonal reset in older adults. Gene profiles in older adults closely resemble those of newborns and children, despite being clonally distinct. Only child-derived and adult-derived A2/M158+CD8+ T cells had the potential to differentiate into highly cytotoxic epitope-specific CD8+ T cells, which was linked to highly functional public T cell receptor (TCR)αβ signatures. Suboptimal TCRαβ signatures in older adults led to less proliferation, polyfunctionality, avidity and recognition of peptide mutants, although displayed no signs of exhaustion. These data suggest that priming T cells at different stages of life might greatly affect CD8+ T cell responses toward viral infections.

Funder

Department of Health | National Health and Medical Research Council

ARC

NIH

Clifford Foundation

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3